Vildagliptin 50 mg & Metformin 500 mg Tablets IP combine two antidiabetic agents that act through complementary mechanisms to effectively lower blood glucose levels in type 2 diabetes. Vildagliptin enhances insulin secretion and suppresses glucagon, while metformin reduces hepatic glucose output and improves insulin sensitivity.